Study challenges old model of lipid balance in metastatic colorectal cancer

Researchers found that an imbalance between sphingosine-1-phosphate and long-chain ceramide in the tumor microenvironment, rather than inside cancer cells, helps metastatic colorectal cancer evade immune attack. Using 574 human colon cancer samples and spatial mapping, they observed that pro-growth lipids rise while a cell-death-promoting lipid falls as the cancer spreads. The findings revise a 30-year-old rheostat theory and suggest new treatment targets.

For three decades, the rheostat concept held that cancer cells internally balance sphingosine-1-phosphate, which encourages growth, against ceramide, which promotes death. The new work instead places this imbalance largely in the tumor microenvironment, where rising S1P and falling long-chain ceramide form a biochemical barrier that keeps immune attackers away.

Using 574 human colon cancer specimens and spatial mapping, researchers linked a three-gene signature to advanced disease, lymph-node spread, poorer survival, and weak immunotherapy responses. In laboratory tests, blocking S1P/S1PR3 let cytotoxic T cells re-enter and attack cancer cells. Colorectal cancer ranks second worldwide in cancer deaths; metastatic disease has a 14% five-year survival rate.